Rebecca Wallace

Title: The Innovations of Rebecca Wallace

Introduction

Rebecca Wallace is a notable inventor based in Ottawa, Canada. She has made significant contributions to the field of microbiology, particularly in the identification of bacterial strains. Her work has implications for public health and disease management.

Latest Patents

Rebecca Wallace holds a patent for the "Identification of Neisseria gonorrhoeae." This invention involves a reagent and test designed for the identification of the bacterium Neisseria gonorrhoeae. The patent utilizes a lipopolysaccharide antigen that is common to various strains of N. gonorrhoeae. The process includes inoculating fowl with this antigen and recovering serum containing antibodies that cause agglutination of the bacterial cells. The identification test is based on the occurrence of cell agglutination, which serves as a positive indicator for the presence of N. gonorrhoeae.

Career Highlights

Rebecca is associated with Canadian Patents & Development Ltd., where she continues to innovate and contribute to her field. Her work has been recognized for its potential impact on diagnosing and treating infections caused by Neisseria gonorrhoeae.

Collaborations

Some of her notable coworkers include Fraser E Ashton and Malcolm B Perry. Their collaboration has likely contributed to the advancements in their respective projects and research.

Conclusion

Rebecca Wallace's contributions to the field of microbiology through her patent on Neisseria gonorrhoeae identification highlight her innovative spirit and dedication to public health. Her work exemplifies the importance of scientific research in combating infectious diseases.